Pharmaceutical Analysis
Regulatory Affairs has a very specific meaning within the healthcare industries. Its regulations are for systematic manufacturing and marketing of safe, efficacious and qualitative drugs. Improving new regulations and adapting to the technology regulatory affairs set new goals and challenges to the pharmaceutical formulation. The global regulatory affairs outsourcing market had a valuation of US$1.9 bn in 2014. The market is expected to expand at a substantial 11.5% CAGR from 2015 to 2023 and rise to a valuation of US$5.7 billion by 2023.
- Novel approaches to analytical and bioanalytical methods
- Bioanalytical techniques
- Chromatography and techniques
- Spectroscopic techniques
- Nuclear magnetic resonanace
- Mass spectroscopy
- Regulatory issues and biosafety challenges in bioanalysis
- Applications of analytical and bioanalytical methods
Related Conference of Pharmaceutical Analysis
Pharmaceutical Analysis Conference Speakers
Recommended Sessions
- Bio-Pharmaceutics
- Biologics & Biosimilars
- Clinical and Hospital Pharmacy
- Clinical Trials and Clinical Research
- Drug Targeting and Design
- Industrial and Physical Pharmacy
- Nanomedicine and Biomedical Applications
- Novel Drug Delivery Systems
- Pharmaceutical Analysis
- Pharmaceutical Biotechnology
- Pharmaceutical Chemistry
- Pharmaceutical Formulation
- Pharmaceutical Manufacturing
- Pharmaceutical Microbiology
- Pharmaceutical Nanotechnology
- Pharmaceutical Packaging
- Pharmaceutical Process Validation
- Pharmacogenetics and Genomics
- Pharmacognosy and Phytochemistry
- Pharmacological Sciences
- Pharmacovigilance and Drug Safety
- Pharmacy Education and Practice
- Regulatory Affairs and Intellectual Property Rights